Improving individualized therapies in T-cell cancers

Our project will create individualized therapy options and strategies to predict treatment response for patients with mature T-cell leukemias/lymphomas.

Learn about our project

News and Events

ERA PerMed JTC2018 Young Scientists Video, 2021-11
Read more
September Consortium meeting in Essen – September 19th, 2019
Read more
Consortium work begins officially – June 1, 2019
Read more

Partners

Satu Mustjoki (MD, PhD)
Hematology Research Unit Helsinki
Translational Immunology research Program
University of Helsinki, Finland
Marco Herling (MD)
Department of Hematology and Oncology
University of Cologne, Germany
Heidi Neubauer (PhD)
Institute of Animal Breeding and Genetics
University of Veterinary Medicine, Vienna, Austria
Patrick Gunning (PhD)
Department of Chemical and Physical Sciences
University of Toronto, Missisauga, Canada
Tero Aittokallio (PhD)
Institute of Molecular Medicine Finland
University of Helsinki, Finland
Benjamin Haibe-Kains (PhD)
Princess Margaret Cancer Center
University Health Network, Canada

Contact

Satu Mustjoki (MD, PhD)

Department of Clinical Chemistry and Hematology
University of Helsinki
Haatmaninkatu 8
Helsinki, Finland, 00290

satu.mustjoki@helsinki.fi

Jenni Hämäläinen (Project Coordinator)

Department of Clinical Chemistry and Hematology
University of Helsinki
Haatmaninkatu 8
Helsinki, Finland, 00290

jenni.e.hamalainen@helsinki.fi

+358 504524919